201. アンジェルマン症候群 Angelman syndrome Clinical trials / Disease details
臨床試験数 : 25 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03644693 (ClinicalTrials.gov) | November 1, 2018 | 13/8/2018 | Nutritional Formulation for Angelman Syndrome | Evaluation of the Safety and Tolerability of a Nutritional Formulation in Angelman Syndrome | Angelman Syndrome | Dietary Supplement: Nutritional Formulation Containing Exogenous Ketones;Dietary Supplement: Placebo Formulation | University of Colorado, Denver | NULL | Completed | 4 Years | 11 Years | All | 15 | N/A | United States |